Skip to main content
HR 6094 118th Congress House Health Health care costs and insurance Health care coverage and access Medicaid Medicare Prescription drugs

Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act

Introduced: February 29, 2024 Introduced by: Matsui, Doris O. Democratic · California See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Nov 3, 2023
Referred to the Subcommittee on Health.
Oct 26, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 26, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act or the PROTECT Rare Act

This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.

What's happening now December 17, 2024

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Lobbying activity 1

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • HARMONY BIOSCIENCES
    for HARMONY BIOSCIENCES · Pennsylvania · 1st Quarter (Jan 1 - Mar 31) 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6094: Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-6094/
MLA
"H.R. 6094: Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-6094/.
Bluebook (legal)
H.R. 6094, 118th Cong. (2026), https://openamerica.io/bill/118-HR-6094/.
Markdown link
[H.R. 6094: Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act](https://openamerica.io/bill/118-HR-6094/)
Report a problem